Dayton Misfeldt
2018
In 2018, Dayton Misfeldt earned a total compensation of $574.9K as Interim CEO at Sunesis Pharmaceuticals.
Compensation breakdown
Option Awards | $524,939 |
---|---|
Other | $50,000 |
Total | $574,939 |
Misfeldt received $524.9K in option awards, accounting for 91% of the total pay in 2018.
Misfeldt also received $50K in other compensation.
Rankings
In 2018, Dayton Misfeldt's compensation ranked 11,427th out of 14,244 executives tracked by ExecPay. In other words, Misfeldt earned more than 19.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,427 | 20th |
Manufacturing | 4,619 | 20th |
Chemicals And Allied Products | 1,752 | 18th |
Drugs | 1,489 | 18th |
Pharmaceutical Preparations | 1,143 | 18th |
Misfeldt's colleagues
We found one more compensation record of an executive who worked with Dayton Misfeldt at Sunesis Pharmaceuticals in 2018.
2018
William Quinn
Sunesis Pharmaceuticals